Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 322
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07815964 Turkish Validity and Reliability of the Parkinson's Disease Neuropsycho… |
Turkish Validity and Reliability … | Parkinson | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Acibadem University | Turkey (Türkiye) · Acibadem University, Istanbul, Tur… | 2026-10-01 → 2027-07-01 | Ouvrir |
| NCT03100149 PASADENA — A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/… |
RO7046015 | Parkinson | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Austria, France, Germany, Spain · Asso… | 2017-06-27 → 2031-12-01 | Ouvrir |
| NCT06920511 OPERA — Cognitive Rehabilitation With Virtual Reality in Parkinson Dise… |
Cognitve rehabilitation with virt… | Parkinson | Non applicable | COMPLETED | En attente / non publié | Fondazione Don Carlo Gnocchi ETS | Italy · Fondazione Don Gnocchi, Sant'Angelo dei Lomba… | 2025-05-01 → 2025-10-31 | Ouvrir |
| NCT07814534 Synthetic Vasomotion for Glymphatic Enhancement |
Active noninvasive vagus nerve st… | Parkinson | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Florida Institute for Human and M… | Non communiqué | 2026-09 → 2026-11 | Ouvrir |
| NCT04810104 PD-MIND — Parkinson's Disease With Mild Cognitive Impairment Treated Wi… |
AZD0328 | Parkinson | Phase 2 | WITHDRAWN | En attente / non publié | King's College London | Non communiqué | 2022-10 → 2024-04 | Ouvrir |
| NCT05413291 Natural History Protocol for Movement Disorders |
Natural History Protocol for Move… | Parkinson | À vérifier | RECRUITING | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2022-10-17 → 2030-12-31 | Ouvrir |
| NCT06272968 Predicting Cognition After DBS for Parkinson's Disease 2 |
Predicting Cognition After DBS fo… | Parkinson | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | Charite University, Berlin, Germa… | Germany · Charite - Universitatsmedizin Berlin, Berli… | 2024-10-01 → 2030-12-01 | Ouvrir |
| NCT07802509 HIHA — DOES HIPPOTHERAPY HAVE AN EFFECT ON MOBILITY, GAIT, BALANCE AND … |
HIHA — DOES HIPPOTHERAPY HAVE AN … | Parkinson | Non applicable | RECRUITING | En attente / non publié | Klinik Valens | Switzerland · Rehabilitation Centre Valens, Valens, S… | 2025-01-01 → 2027-01-01 | Ouvrir |
| NCT04932434 PDP1 — Psilocybin Therapy for Depression and Anxiety in Parkinson's Dis… |
Psilocybin therapy | Parkinson | Phase 2 | COMPLETED | En attente / non publié | Joshua Woolley, MD, PhD | United States · University of California, San Francis… | 2021-08-15 → 2024-12-31 | Ouvrir |
| NCT07725562 VG081821AC Tablets for Early to Mid-stage Parkinson's Disease |
VG081821AC | Parkinson | Phase 2/3 | RECRUITING | En attente / non publié | Zhejiang Vimgreen Pharmaceuticals… | China · Xuanwu Hospital of Capital Medical University… | 2026-07-17 → 2027-10-31 | Ouvrir |
| NCT07461220 LIFT-PD — Safety and Tolerability of IRL757 in Participants With Parkin… |
IRL757 | Parkinson | Phase 1/2 | RECRUITING | En attente / non publié | Integrative Research Laboratories… | Bulgaria, Germany, Poland, Spain · Centrum Medyczne N… | 2026-02-18 → 2027-05 | Ouvrir |
| NCT06234995 Cortical Electrophysiology of Response Inhibition in Parkinson's Disease |
Levodopa | Parkinson | Phase 4 | RECRUITING | En attente / non publié | Emory University | United States · Emory Brain Health Center, Atlanta, U… | 2021-08-09 → 2027-09 | Ouvrir |
| NCT06170788 TroFuse-007 — Sacituzumab Tirumotecan (MK-2870) in Combination With Pem… |
Sacituzumab Tirumotecan | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Brazil, Canada, … | 2023-12-15 → 2030-05-27 | Ouvrir |
| NCT06618157 Connectomic Guided DBS for Parkinson's Disease |
Cerebellothalamic optimized deep … | Parkinson | Non applicable | ENROLLING_BY_INVITATION | En attente / non publié | Duke University | United States · Duke Health Center at Morreene Road, … | 2026-02-16 → 2027-01-29 | Ouvrir |
| NCT06690931 recoveriX PD — Neurofeedback Rehabilitation With FES and VR for PD |
Brain-Computer Interface with FES… | Parkinson | Non applicable | COMPLETED | En attente / non publié | g.tec medical engineering GmbH | Austria · g.tec medical engineering GmbH, Schiedlberg… | 2024-12-09 → 2026-06-25 | Ouvrir |
| NCT01989013 Effect on Parkinson's Disease After Therapeutic Induction of CranioSacr… |
Effect on Parkinson's Disease Aft… | Parkinson | Non applicable | ENROLLING_BY_INVITATION | En attente / non publié | Zia, Al Raza | United States · Naturalmed therapy, Ann Arbor, United… | 2014-02 → 2027-01 | Ouvrir |
| NCT07216703 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination Wi… |
Pembrolizumab | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Austria, Belgium, Brazil, C… | 2026-01-19 → 2031-10-29 | Ouvrir |
| NCT04691661 Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib … |
Radotinib HCl 50 mg | Parkinson | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Il-Yang Pharm. Co., Ltd. | France · CHRU de Lille - Hôpital Roger Salengro, Lill… | 2021-09-09 → 2027-04-30 | Ouvrir |
| NCT03811405 Physiology, Imaging and Modeling of Essential Tremor |
Active biphasic pulse stimulation… | Parkinson | Non applicable | COMPLETED | En attente / non publié | University of Florida | United States · McKnight Brain Institute--Fixel Cente… | 2021-04-01 → 2025-06-01 | Ouvrir |
| NCT05511597 SBT FOG-TRAIN — Split-belt Treadmill Training for Freezing of Gait in P… |
SBT FOG-TRAIN — Split-belt Treadm… | Parkinson | Non applicable | COMPLETED | En attente / non publié | KU Leuven | Belgium · Faculty of Movement and Rehabilitation Scie… | 2022-12-16 → 2026-03-17 | Ouvrir |
| NCT06445972 Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophagea… |
Ramucirumab | Parkinson | Phase 1/2 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States, Brazil, Chile, China, France, Germany,… | 2024-08-07 → 2030-08-08 | Ouvrir |
| NCT05967598 Effect of taVNS of Brainstem Activation in Early and Late Parkinson's D… |
Noninvasive transcutaneous auricu… | SEP | Non applicable | COMPLETED | En attente / non publié | University of Ljubljana | Slovenia · Neurology Department, UMC Ljubljana, Ljubl… | 2023-02-15 → 2023-09-29 | Ouvrir |
| NCT07002034 RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Ot… |
RE104 for Injection | Sclérose latérale amyotrophique | Phase 2 | RECRUITING | En attente / non publié | Reunion Neuroscience Inc | United States · Alliance for Multispecialty Research … | 2025-07-30 → 2026-12 | Ouvrir |
| NCT01562496 The ParkCycle Study: Aerobic Exercise in PD |
The ParkCycle Study: Aerobic Exer… | Parkinson | Non applicable | COMPLETED | En attente / non publié | Radboud University Medical Center | United States, Netherlands · Cleveland Clinic, Clevel… | 2012-01 → 2014-10 | Ouvrir |
| NCT02114242 BIOPARK — Biomarkers in Parkinsonian Syndromes |
BIOPARK — Biomarkers in Parkinson… | Parkinson | À vérifier | UNKNOWN | En attente / non publié | University Hospital, Bordeaux | France · CHU de Bordeaux, Pessac, France | CHU de Lim… | 2013-12-16 → 2025-12-16 | Ouvrir |